ANDREW GUGGENHIME
CIK 1230724 · PRESIDENT AND CFO · last filed 2026-03-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.50M
Companies
6
Total Filings
81
Lifetime Open-Market Net
-$19.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCVX | PRESIDENT AND CFO | 166,245 | $47.46 | $7.89M | -$17.06M | 46 | 2026-03-11 |
| CRBU | Director | — | $1.59 | — | $0 | 5 | 2026-02-20 |
| Metacrine, Inc. (MTCR) Delisted | Director | — | $0.49 | — | $0 | 2 | 2022-09-06 |
| DERM | CFO | 42,159 | $6.34 | $267.3K | -$1.98M | 15 | 2019-08-19 |
| FACT | SVP & CFO | 32,090 | $10.65 | $341.8K | $0 | 5 | 2010-04-21 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | SVP & Chief Financial Officer | 13,255 | — | — | $0 | 5 | 2008-12-19 |
Recent Filings · Page 8 of 9
81 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-23 | — | Disp (D) | −32,090 | -$866.4K | |
| 2010-04-21 | FACT | U | −12,383 | -$334.3K | EDGAR |
| 2010-04-05 | FACT | Tax (F) | −1,516 | -$40.9K | EDGAR |
| 2009-08-10 | FACT | Grant (A) | +15,251 | $0 | EDGAR |
| 2009-04-06 | FACT | Mixed | −1,478 | -$14.5K | EDGAR |
| 2009-01-27 | FACT | Grant (A) | +29,600 | $0 | EDGAR |
| 2008-12-19 | PDL BIOPHARMA, INC. (PDLI) Delisted | Tax (F) | −3,575 | $0 | EDGAR |
| 2008-06-23 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2007-08-17 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-30 | PDL BIOPHARMA, INC. (PDLI) Delisted | Tax (F) | −670 | -$14.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.